Sanyo dual-cooling freezer provides sample security

Published: 30-Jun-2011
Manufacturing Research & Development

The upright 728l model is ideal for valuable research or clinical samples

Sanyo has expanded its range of dual-cooling -86°C freezers with the launch of the extra-large capacity MDF-U700VX, an upright 728 litre model which provides maximum sample security for valuable research or clinical samples.

With two independent refrigeration systems the dual-cooling freezers maintain a reliable and uniform -86°C ultralow temperature environment. Should one cooling system suffer an unexpected failure, the other circuit will keep irreplaceable samples safely around -70°C until service can be arranged. This freezer design not only protects precious samples but also prevents the inconvenience and expense of out-of-hours call-outs in the event of a failure of one of the refrigeration systems.

The MDF-U700VX has an extra-large capacity of 728 litres without taking up extra space, thanks to its VIP Plus high efficiency vacuum insulation. In addition to reducing energy use, VIP Plus provides typically 24% more storage capacity compared with a conventionally insulated freezer with the same footprint.

This latest dual-cooling unit offers Sanyo’s industry-first intelligent ECO Mode, optimising compressor operation to match the freezer’s running conditions and minimise energy use. Efficient long-term operation of the freezer is facilitated by the filter-less condenser design, which eliminates the need for routine filter cleaning.

The central door-mounted LCD display panel provides intuitive programming of set points and clear confirmation of freezer status. An on-board data logging function allows the operator to easily check recent freezer performance. Other user-friendly design features include comprehensive alarms, a vacuum release port for smooth door opening, and quiet operation.

The MDF-U700VX is certified as a Class IIa Medical Device (93/42/EEC and 2007/47/EC).

See more

You may also like

Manufacturing

MIR-S100C offers secure operation for cell culture

Read more
For use in high humidity conditions

Trending Articles

  1. IMA Life-Sharp Sterile Manufacturing partnership strengthened with aseptic technology facility Sharp's expanded facility in Massachusetts will include the installation of a fully automated IMA Life isolated filling line for Ready-To-Use (RTU) vials, addressing demand for US-based aseptic fill-finish services
  2. FDA and EMA issue guiding principles for AI in drug development The set of ten principles gives broad guidance on AI use in evidence generation and monitoring across all phases of a medicine, from early research and clinical trials to manufacturing and safety monitoring
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Miniaturisation in medtech: mechanical factors that influence product success Medical devices are becoming smaller, lighter and more portable. From handheld diagnostic tools to wearable infusion pumps and compact surgical instruments, reduced size is now a defining feature of many new medtech products
  4. Enara Bio expands Boehringer Ingelheim partnership as DARKFOX programme moves toward the clinic Enara Bio has entered 2026 with renewed momentum after Boehringer Ingelheim licensed additional Dark Antigen targets under their oncology collaboration. The company is also continuing to expand its EDAPT discovery platform
  5. Thermo Fisher unveils HepatoExpress kit for liver cell gene expression analysis The new Invitrogen TaqMan Cells-to-CT HepatoExpress Kit eliminates the need for traditional RNA purification, streamlining workflows and reducing time to results and offers less plastic waste compared to traditional RNA purification methods

Upcoming event

Pharmapack

21–22 January 2026 | Exhibition | Paris, France See all

You may also like

Manufacturing

MIR-S100C offers secure operation for cell culture

For use in high humidity conditions
Containment

Sanyo installs first cell processing workstation in US

To be used to advance stem cell and cell therapy research at the University of Alabama at Birmingham
Manufacturing

Sanyo incubator offers uniform culturing environment

Includes optional hydrogen peroxide decontamination system
Research & Development

Merck and Moderna announce 5-year data for intismeran autogene in combination with KEYTRUDA

Eight Phase II and Phase III clinical trials are under way across multiple tumour types, including melanoma, non-small cell lung cancer, bladder cancer and renal cell carcinoma
Manufacturing

OMRON introduces new high-payload collaborative robots and TMflow software upgrade

OMRON unveils advanced collaborative robots and upgraded TMflow software to boost manufacturing flexibility and productivity
Manufacturing

Sharp Services invests more than €20m to expand injectables packaging capacity at its European facilities

Expansion includes significant cold chain warehouse capacity to support injectable formats
Manufacturing

Key drivers behind the rise of microsphere drug delivery systems

Microspheres shift drug delivery from broad distribution to precise targeting. These systems improve therapeutic consistency, lower systemic exposure, and adapt to complex treatment regimens. Their growth reflects progress in polymer science, pharmacokinetics, and the push for more individualised care in clinical settings. Let’s explore some of the key drivers behind the rise of microsphere drug delivery systems and look ahead to predict future growth trends
Subscribe now